Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 163

    1.

    A risk score for mortality after allogeneic hematopoietic cell transplantation.

    Parimon T, Au DH, Martin PJ, Chien JW.

    Ann Intern Med. 2006 Mar 21;144(6):407-14.PMID: 16549853 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Value of the pretransplant evaluation in predicting toxic day-100 mortality among blood stem-cell and bone marrow transplant recipients.

    Goldberg SL, Klumpp TR, Magdalinski AJ, Mangan KF.

    J Clin Oncol. 1998 Dec;16(12):3796-802.PMID: 9850024 [PubMed - indexed for MEDLINE]Related articles

    4.

    Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.

    Maury S, Balère-Appert ML, Chir Z, Boiron JM, Galambrun C, Yakouben K, Bordigoni P, Marie-Cardine A, Milpied N, Kanold J, Maillard N, Socié G; French Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).

    Haematologica. 2007 May;92(5):589-96.PMID: 17488681 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality.

    Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA.

    Clin Infect Dis. 2007 Feb 15;44(4):531-40. Epub 2007 Jan 9.PMID: 17243056 [PubMed - indexed for MEDLINE]Related articles

    6.

    Carbon monoxide diffusion capacity: how low can you go for hematopoietic cell transplantation eligibility?

    Chien JW, Sullivan KM.

    Biol Blood Marrow Transplant. 2009 Apr;15(4):447-53.PMID: 19285632 [PubMed - indexed for MEDLINE]Related articles

    7.

    Mechanical ventilation in hematopoietic stem cell transplantation: can We effectively predict outcomes?

    Shorr AF, Moores LK, Edenfield WJ, Christie RJ, Fitzpatrick TM.

    Chest. 1999 Oct;116(4):1012-8.PMID: 10531167 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation.

    Wirk B, Klumpp TR, Ulicny J, Herman JH, Gajewski JL, Martin ME, Emmons RV, Mangan KF.

    Transfusion. 2008 Jan;48(1):163-8. Epub 2007 Sep 27.PMID: 17900280 [PubMed - indexed for MEDLINE]Related articles

    9.

    Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.

    Tichelli A, Passweg J, Wójcik D, Rovó A, Harousseau JL, Masszi T, Zander A, Békássy A, Crawley C, Arat M, Sica S, Lutz P, Socié G; EBMT Late Effects Working Party.

    Haematologica. 2008 Aug;93(8):1203-10. Epub 2008 Jun 12.PMID: 18556401 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Physicians' prognostic estimates of survival for patients undergoing allogeneic hematopoietic stem cell transplantation.

    Grulke N, Bunjes D, Larbig W, Kächele H, Bailer H.

    J Psychosom Res. 2008 Jul;65(1):61-6. Epub 2008 Jun 4.PMID: 18582613 [PubMed - indexed for MEDLINE]Related articles

    11.

    Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.

    Sorror ML, Sandmaier BM, Storer BE, Maris MB, Baron F, Maloney DG, Scott BL, Deeg HJ, Appelbaum FR, Storb R.

    J Clin Oncol. 2007 Sep 20;25(27):4246-54. Epub 2007 Aug 27.PMID: 17724349 [PubMed - indexed for MEDLINE]Related articles

    12.

    Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation.

    Chien JW, Martin PJ, Gooley TA, Flowers ME, Heckbert SR, Nichols WG, Clark JG.

    Am J Respir Crit Care Med. 2003 Jul 15;168(2):208-14. Epub 2003 Mar 20.PMID: 12649126 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant.

    Parikh CR, McSweeney P, Schrier RW.

    Kidney Int. 2005 May;67(5):1999-2005.PMID: 15840050 [PubMed - indexed for MEDLINE]Related articles

    14.

    Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants.

    Passweg JR, Walker I, Sobocinski KA, Klein JP, Horowitz MM, Giralt SA; Chronic Leukemia Study Writing Committee of the International Bone Marrow Transplant Registry.

    Br J Haematol. 2004 Jun;125(5):613-20.PMID: 15147377 [PubMed - indexed for MEDLINE]Related articles

    15.

    Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia.

    Spinelli O, Peruta B, Tosi M, Guerini V, Salvi A, Zanotti MC, Oldani E, Grassi A, Intermesoli T, Micò C, Rossi G, Fabris P, Lambertenghi-Deliliers G, Angelucci E, Barbui T, Bassan R, Rambaldi A.

    Haematologica. 2007 May;92(5):612-8.PMID: 17488684 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index.

    Blanchon F, Grivaux M, Asselain B, Lebas FX, Orlando JP, Piquet J, Zureik M.

    Lancet Oncol. 2006 Oct;7(10):829-36.PMID: 17012045 [PubMed - indexed for MEDLINE]Related articles

    17.

    An externally validated model for predicting long-term survival after exercise treadmill testing in patients with suspected coronary artery disease and a normal electrocardiogram.

    Lauer MS, Pothier CE, Magid DJ, Smith SS, Kattan MW.

    Ann Intern Med. 2007 Dec 18;147(12):821-8.PMID: 18087052 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC).

    Vigouroux S, Michallet M, Porcher R, Attal M, Ades L, Bernard M, Blaise D, Tabrizi R, Garban F, Cassuto JP, Chevalier P, Facon T, Ifrah N, Renaud M, Tilly H, Vernant JP, Kuentz M, Bourhis JH, Bordigoni P, Deconinck E, Lioure B, Socié G, Milpied N; French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC).

    Haematologica. 2007 May;92(5):627-34.PMID: 17488686 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Depression, cigarette smoking, and hematopoietic stem cell transplantation outcome.

    Chang G, Orav EJ, McNamara T, Tong MY, Antin JH.

    Cancer. 2004 Aug 15;101(4):782-9.PMID: 15305410 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

    Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B.

    Blood. 2005 Oct 15;106(8):2912-9. Epub 2005 Jun 30.PMID: 15994282 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data